SLC2A1 and central nervous system cancer: There were 44 (66.7%) positive cases of GLUT1 when GLUT1 membranous expression was evaluated in the invasive front of diffuse infiltrative glioma cells independent of necrotic areas (Figure 5G and Supplementary Table S5).